107 related articles for article (PubMed ID: 8128845)
1. The detection of the c-myc and ras oncogenes in nasopharyngeal carcinoma by immunohistochemistry.
Porter MJ; Field JK; Leung SF; Lo D; Lee JC; Spandidos DA; van Hasselt CA
Acta Otolaryngol; 1994 Jan; 114(1):105-9. PubMed ID: 8128845
[TBL] [Abstract][Full Text] [Related]
2. Oncogene protein co-expression. Value of Ha-ras, c-myc, c-fos, and p53 as prognostic discriminants for breast carcinoma.
Bland KI; Konstadoulakis MM; Vezeridis MP; Wanebo HJ
Ann Surg; 1995 Jun; 221(6):706-18; discussion 718-20. PubMed ID: 7794075
[TBL] [Abstract][Full Text] [Related]
3. Expression of ras and myc oncogenes in human hepatocellular carcinoma and non-neoplastic liver tissues.
Tiniakos D; Spandidos DA; Kakkanas A; Pintzas A; Pollice L; Tiniakos G
Anticancer Res; 1989; 9(3):715-21. PubMed ID: 2548435
[TBL] [Abstract][Full Text] [Related]
4. Detection of c-myc gene expression in nasopharyngeal carcinoma by nonradioactive in situ hybridization and immunohistochemistry.
Luo J; Xiao J; Tao Z; Li X
Chin Med J (Engl); 1997 Mar; 110(3):229-32. PubMed ID: 9594347
[TBL] [Abstract][Full Text] [Related]
5. Expression of cellular oncogenes in human gastric carcinoma: c-myc, c-erb B2, and c-Ha-ras.
Kim YJ; Ghu HD; Kim DY; Kim HJ; Kim SK; Park CS
J Surg Oncol; 1993 Nov; 54(3):167-70. PubMed ID: 8412172
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical study of oncogene product ras p21, c-myc and growth factor EGF in breast carcinomas.
Mizukami Y; Nonomura A; Noguchi M; Taniya T; Koyasaki N; Saito Y; Hashimoto T; Matsubara F; Yanaihara N
Anticancer Res; 1991; 11(4):1485-94. PubMed ID: 1660689
[TBL] [Abstract][Full Text] [Related]
7. Loss of heterozygosity and its correlation with clinical outcome and Epstein-Barr virus infection in nasopharyngeal carcinoma.
Shao JY; Huang XM; Yu XJ; Huang LX; Wu QL; Xia JC; Wang HY; Feng QS; Ren ZF; Ernberg I; Hu LF; Zeng YX
Anticancer Res; 2001; 21(4B):3021-9. PubMed ID: 11712805
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical expression of fatty acid synthase, apoptotic-regulating genes, proliferating factors, and ras protein product in colorectal adenomas, carcinomas, and adjacent nonneoplastic mucosa.
Visca P; Alò PL; Del Nonno F; Botti C; Trombetta G; Marandino F; Filippi S; Di Tondo U; Donnorso RP
Clin Cancer Res; 1999 Dec; 5(12):4111-8. PubMed ID: 10632348
[TBL] [Abstract][Full Text] [Related]
9. c-myc gene inactivation during induction of nasopharyngeal carcinoma cells with retinoic acid.
Jiang N; Zhan F; Cao L; Yao K; Li G
Chin Med J (Engl); 2000 Sep; 113(9):823-6. PubMed ID: 11776079
[TBL] [Abstract][Full Text] [Related]
10. ras and c-myc protein expression in colorectal carcinoma. Study of cancer-prone patients.
Miller F; Heimann TM; Quish A; Pyo DJ; Szporn A; Martinelli G; Fasy TM
Dis Colon Rectum; 1992 May; 35(5):430-5. PubMed ID: 1568393
[TBL] [Abstract][Full Text] [Related]
11. Nuclear expression of CDK4 correlates with disease progression and poor prognosis in human nasopharyngeal carcinoma.
Jiang Q; Mai C; Yang H; Wu Q; Hua S; Yan C; Long Y; Zhang Y; Long X; Fang W; Liu Z
Histopathology; 2014 Apr; 64(5):722-30. PubMed ID: 24168228
[TBL] [Abstract][Full Text] [Related]
12. Epstein-Barr virus-related serology in nasopharyngeal carcinoma and controls.
Henle W; Henle G; Ho JH
IARC Sci Publ (1971); 1978; (20):427-37. PubMed ID: 215525
[No Abstract] [Full Text] [Related]
13. Phosphotyrosine, p62 c-myc and p21 c-Ha-ras proteins in colonic epithelium of normal and dimethylhydrazine-treated rats: an immunohistochemical analysis.
Schwartz B; Benharroch D; Prinsloo I; Cagnano E; Lamprecht SA
Anticancer Res; 1995; 15(1):211-8. PubMed ID: 7537485
[TBL] [Abstract][Full Text] [Related]
14. Expressions of N-myc and ras oncogene products in neuroblastoma and their correlations with prognosis.
Nakada K; Fujioka T; Kitagawa H; Takakuwa T; Yamate N
Jpn J Clin Oncol; 1993 Jun; 23(3):149-55. PubMed ID: 8350488
[TBL] [Abstract][Full Text] [Related]
15. Low levels of ras p21 oncogene expression correlates with clinical outcome in head and neck squamous cell carcinoma.
Field JK; Yiagnisis M; Spandidos DA; Gosney JR; Papadimitriou K; Vaughan ED; Stell PM
Eur J Surg Oncol; 1992 Apr; 18(2):168-76. PubMed ID: 1582509
[TBL] [Abstract][Full Text] [Related]
16. Confocal laser scanning microscopy of oncogene localization in rainbow trout cell lines derived from normal and tumor tissue.
Carter CA; Ellington WW; Van Beneden RJ
Toxicol Pathol; 1996; 24(3):339-45. PubMed ID: 8736390
[TBL] [Abstract][Full Text] [Related]
17. Implication of the ras and myc oncoproteins in the pathogenesis of mycosis fungoides.
Tosca A; Linardopoulos S; Malliri A; Hatziolou E; Nicolaidou A; Spandidos DA
Anticancer Res; 1991; 11(4):1433-8. PubMed ID: 1746900
[TBL] [Abstract][Full Text] [Related]
18. Reactive nitrogen species-dependent DNA damage in EBV-associated nasopharyngeal carcinoma: the relation to STAT3 activation and EGFR expression.
Ma N; Kawanishi M; Hiraku Y; Murata M; Huang GW; Huang Y; Luo DZ; Mo WG; Fukui Y; Kawanishi S
Int J Cancer; 2008 Jun; 122(11):2517-25. PubMed ID: 18307254
[TBL] [Abstract][Full Text] [Related]
19. Expression of c-myc oncogene product and ras family oncogene products in various human malignant lymphomas defined by immunohistochemical techniques.
Mitani S; Sugawara I; Shiku H; Mori S
Cancer; 1988 Nov; 62(10):2085-93. PubMed ID: 3052780
[TBL] [Abstract][Full Text] [Related]
20. A prospective study of p53 expression and its correlation with clinical response of radiotherapy in nasopharyngeal carcinoma.
Ho KY; Kuo WR; Chai CY; Tsai SM; Sheu SH; Wu SC; Juan KH
Laryngoscope; 2001 Jan; 111(1):131-6. PubMed ID: 11192881
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
